Puretech Health PLC - ADRPRTCY
13F holders, Q3 2024 (September 30)4holders −2
0new positions
2sold out
$20.61avg. 13F price*
At the end of Q3 2024, 4 institutions reported holding Puretech Health PLC - ADR (PRTCY) in their 13F filings, down 2 from Q2 2024. 0 opened new positions and 2 sold out. The largest holders were Pentwater Capital Management LP ($515K), ADAR1 Capital Management, LLC ($62K) and UBS Group AG ($13K).
- Company
- Puretech Health PLC - ADR
- CUSIP
- 746237106
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $704K |
All 13F filers, Q2 2024 → Q3 2024: 11,403 shares bought and 304,800 shares sold, net −293,397 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Pentwater Capital Management LP | 0.01% | Add +54.4% | 25,000 | $515K |
| ADAR1 Capital Management, LLC | 0.01% | Add +328.6% | 3,000 | $62K |
| UBS Group AG | 0.00% | Add +84.3% | 647 | $13K |
| Morgan Stanley | 0.00% | Reduce -96.5% | 100 | $2K |
"% of holder's portfolio" is PRTCY's weight in each manager's 13F, not the share of Puretech Health PLC - ADR the manager owns.